Literature DB >> 16735724

A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced infectivity in cell culture.

Catherine M O'Connell1, Kristy M Nicks1.   

Abstract

A highly conserved cryptic plasmid is present in Chlamydia trachomatis yet naturally occurring plasmid-deficient isolates are very rare. This paper describes the isolation and characterization of a plasmid-deficient strain of C. muridarum, using novobiocin as a curing agent. Plasmid-deficient derivatives of C. muridarum strain Nigg were generated at high efficiencies (4-30%). Phenotypic characterization revealed that the cured derivative was unable to accumulate glycogen within intracytoplasmic inclusions. In addition, this strain formed small plaques at a reduced efficiency compared to the wild-type parent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735724     DOI: 10.1099/mic.0.28658-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  57 in total

1.  The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection.

Authors:  Melissa M Riley; Matthew A Zurenski; Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Margaret Mintus; Toni Darville
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

2.  Infectivity acts as in vivo selection for maintenance of the chlamydial cryptic plasmid.

Authors:  Marsha Russell; Toni Darville; Kumar Chandra-Kuntal; Bennett Smith; Charles W Andrews; Catherine M O'Connell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Intrauterine infection with plasmid-free Chlamydia muridarum reveals a critical role of the plasmid in chlamydial ascension and establishes a model for evaluating plasmid-independent pathogenicity.

Authors:  Jianlin Chen; Zhangsheng Yang; Xin Sun; Lingli Tang; Yiling Ding; Min Xue; Zhiguang Zhou; Joel Baseman; Guangming Zhong
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

4.  Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms.

Authors:  Hector A Saka; J Will Thompson; Yi-Shan Chen; Yadunanda Kumar; Laura G Dubois; M Arthur Moseley; Raphael H Valdivia
Journal:  Mol Microbiol       Date:  2011-11-07       Impact factor: 3.501

5.  The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells.

Authors:  Zhongyu Li; Ding Chen; Youmin Zhong; Shiping Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

6.  A major advance in elucidating the biology/pathobiology of Chlamydia trachomatis.

Authors:  Alan P Hudson
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

7.  Plasmid-mediated transformation tropism of chlamydial biovars.

Authors:  Lihua Song; John H Carlson; Bing Zhou; Kimmo Virtaneva; William M Whitmire; Gail L Sturdevant; Stephen F Porcella; Grant McClarty; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2013-11-11       Impact factor: 3.166

8.  The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor.

Authors:  John H Carlson; William M Whitmire; Deborah D Crane; Luke Wicke; Kimmo Virtaneva; Daniel E Sturdevant; John J Kupko; Stephen F Porcella; Neysha Martinez-Orengo; Robert A Heinzen; Laszlo Kari; Harlan D Caldwell
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

9.  A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.

Authors:  Taylor B Poston; Yanyan Qu; Jenna Girardi; Catherine M O'Connell; Lauren C Frazer; Ali N Russell; McKensie Wall; Uma M Nagarajan; Toni Darville
Journal:  J Immunol       Date:  2017-08-30       Impact factor: 5.422

10.  Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle.

Authors:  Rachel J Skilton; Lesley T Cutcliffen; David Barlow; Yibing Wang; Omar Salim; Paul R Lambden; Ian N Clarke
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.